Alexandra Vladimirovna Semyanikhina

Alexandra Vladimirovna Semyanikhina

Auto-generated profile, based on publicly available information

Alexandra Vladimirovna Semyanikhina


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2023 in Cancer Biology & Medicine
Verified
Journal Article
Open access
PDF file
MNMaxim Petrovich Nikulin
Maxim Petrovich Nikulin
NSNadezhda Vladimirovna Shilova
Nadezhda Vladimirovna Shilova
ALAlexander Dmitrievich Lipatnikov
Alexander Dmitrievich Lipatnikov
ISIvan Sokratovich Stilidi
Ivan Sokratovich Stilidi
ASAlexandra Vladimirovna Semyanikhina
Alexandra Vladimirovna Semyanikhina
NTNikolai Nikolaevich Tupitsyn
Nikolai Nikolaevich Tupitsyn

Verified
Journal Article
Open access
PDF file
MNMaxim Petrovich Nikulin
Maxim Petrovich Nikulin
ALAlexander D. Lipatnikov
Alexander D. Lipatnikov
ANAlexey Nokel
Alexey Nokel
SPSvetlama Polyakova
Svetlama Polyakova
STSvetlana V. Tsygankova
Svetlana V. Tsygankova
NSNadezhda Shilova
Nadezhda Shilova
A key function of naturally occurring antibodies is to control pathologically altered cells, such as those with aberrant glycosylation. Age-related diminution in the pool of B cells producing these immunoglobulins is linked to impaired anti-tumor immunity. In this study, the levels of antibodies against tumor-associated carbohydrate antigens (TACAs)—common in gastric cancer (GC) and other malignancies—were analyzed in 235 treatment-naïve GC patients (stages I–IV) and 76 healthy donors using a printed glycan array (PGA). We found that anti-glycan IgM levels, but not IgG, reduced with age in both patients and donors. Crucially, IgM levels against most glycans were significantly lower in the GC cohort compared with healthy donors, a trend that remained after age adjustment. Furthermore, an immunohistochemical analysis revealed that human anti-GalNAcα (Tn) antibodies—a well-characterized TACA in gastrointestinal cancers—bound to tumor cells and exhibited perinuclear and membrane staining in non-tumor surface cells within the same organ. These data support the hypothesis that gastric cancer patients have reduced levels of anti-glycan IgMs, which are responsible for the early recognition of transformed cells. This specific immunodeficiency may contribute to a permissive environment for tumor development.

1 January 2019
Verified
Journal Article
Open access
ASA.V. Semyanikhina
A.V. Semyanikhina
NPN.I. Pospekhova
N.I. Pospekhova